RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..9 of 9 - per page
Order by
Topical Diclofenac Products
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
Transdermal Fentanyl
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
Product enhancement of small and large molecules in a range of dosage forms
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Stabilisation and rapid reconstitution of biopharmaceuticals
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Total Synthesis of Northebaine, Normorphine, Noroxymorphone Enantiomers and Derivatives via N-Nor Intermediates
Method of making key intermediates useful in the synthesis of many opiate narcotics and antagonists and agonists; and the non-opiate enantiomers thereof which have potent antitussive properties. More
Metabolic profiling methods and compositions to control Warfarin therapy: personalized medicine for control of coagulation therapy (09-26)
Metabolomic assessment of the different Cytochrome P450 and UDP-Glucuronosyltransferase contributions to Warfarin Metabolism in individual patients More
CollaRx® & LiquiColl® Technologies
Collagen-based biodegradable matrices for localized drug delivery More
Displaying 1..9 of 9 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Moderate to Severe Chronic Nociceptive Pain Market Forecast
Aug 2010 - $15,200
Pain Therapeutics, Inc.: SWOT Analysis & Company Profile
Apr 2010 - 22 pages - $99
Epidemiology: Chronic Lower Back Pain – Millions will continue to be out of work over the next decade
Nov 2011 - 40 pages - $5,700
Chronic Pancreatitis Pain - Pipeline Review, Q1 2011
Jan 2011 - 18 pages - $500
Chronic Pancreatitis Pain - Pipeline Review, Q3 2011
Jul 2011 - 26 pages - $500
Chronic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Apr 2011 - 101 pages - $2,000
Pain Therapeutics, Inc. - SWOT Analysis
Jun 2010 - 22 pages - $125
R&D Trends: Acute Pain - Reformulations dominate amid paucity of innovative pipeline candidates
Oct 2011 - 68 pages - $3,800
Evolution in the Pain Therapy Drugs Market: Nociceptive and Neuropathic Drug Development
Jan 2012 - 126 pages - $2,265
The Pain Market Outlook to 2016
Jul 2011 - 155 pages - $3,835
More Related Market Research Reports >>>

Your selection

Therapeutic target
Central Nervous System del
Pain del
Pain, chronic del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us